Correlation Between UNIQA Insurance and International Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UNIQA Insurance and International Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UNIQA Insurance and International Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UNIQA Insurance Group and International Biotechnology Trust, you can compare the effects of market volatilities on UNIQA Insurance and International Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UNIQA Insurance with a short position of International Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of UNIQA Insurance and International Biotechnology.

Diversification Opportunities for UNIQA Insurance and International Biotechnology

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between UNIQA and International is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding UNIQA Insurance Group and International Biotechnology Tr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Biotechnology and UNIQA Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UNIQA Insurance Group are associated (or correlated) with International Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Biotechnology has no effect on the direction of UNIQA Insurance i.e., UNIQA Insurance and International Biotechnology go up and down completely randomly.

Pair Corralation between UNIQA Insurance and International Biotechnology

Assuming the 90 days trading horizon UNIQA Insurance Group is expected to generate 0.65 times more return on investment than International Biotechnology. However, UNIQA Insurance Group is 1.55 times less risky than International Biotechnology. It trades about 0.05 of its potential returns per unit of risk. International Biotechnology Trust is currently generating about 0.02 per unit of risk. If you would invest  682.00  in UNIQA Insurance Group on November 2, 2024 and sell it today you would earn a total of  132.00  from holding UNIQA Insurance Group or generate 19.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.59%
ValuesDaily Returns

UNIQA Insurance Group  vs.  International Biotechnology Tr

 Performance 
       Timeline  
UNIQA Insurance Group 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in UNIQA Insurance Group are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, UNIQA Insurance unveiled solid returns over the last few months and may actually be approaching a breakup point.
International Biotechnology 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in International Biotechnology Trust are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, International Biotechnology may actually be approaching a critical reversion point that can send shares even higher in March 2025.

UNIQA Insurance and International Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UNIQA Insurance and International Biotechnology

The main advantage of trading using opposite UNIQA Insurance and International Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UNIQA Insurance position performs unexpectedly, International Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Biotechnology will offset losses from the drop in International Biotechnology's long position.
The idea behind UNIQA Insurance Group and International Biotechnology Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements